CPRX - CATALYST PHARMACEUTICALS, INC.
IEX Last Trade
21.92
0.110 0.502%
Share volume: 12,244
Last Updated: Fri 27 Dec 2024 02:30:03 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
0.33%
PREVIOUS CLOSE
CHG
CHG%
$21.81
0.11
0.50%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-09 | 2022-11-09 | 2023-03-15 | 2023-05-10 | 2023-08-09 | 2023-11-08 | 2024-02-28 | 2024-05-08 | |
| Total revenue | 53.113 M | 57.244 M | 60.757 M | 85.366 M | 99.582 M | 102.688 M | 110.568 M | 98.509 M | |
| Cost of revenue | 7.643 M | 9.665 M | 11.195 M | 9.946 M | 12.045 M | 14.167 M | 15.809 M | 12.520 M | |
| Gross profit | 45.470 M | 47.579 M | 49.562 M | 75.420 M | 87.537 M | 88.521 M | 94.759 M | 85.989 M | |
| 4.64% | 4.17% | 52.17% | 16.07% | 1.12% | 7.05% | -9.26% | |||
| Operating expenses | 16.901 M | 22.477 M | 18.761 M | 33.280 M | 32.350 M | 117.222 M | 44.008 M | 49.519 M | |
| Selling general and admin | 12.918 M | 14.167 M | 14.668 M | 29.718 M | 28.396 M | 33.560 M | 42.036 M | 46.938 M | |
| Research and development | 3.983 M | 8.310 M | 4.093 M | 3.562 M | 3.954 M | 83.662 M | 1.972 M | 2.581 M | |
| Total expenses | 24.544 M | 32.142 M | 29.956 M | 49.757 M | 52.883 M | 139.876 M | 68.876 M | 71.383 M | |
| 30.96% | -6.80% | 66.10% | 6.28% | 164.50% | -50.76% | 3.64% | |||
| Operating income | 28.569 M | 25.102 M | 30.801 M | 35.609 M | 46.699 M | -37.188 M | 41.692 M | 27.126 M | |
| Ebit | 28.569 M | 25.102 M | 30.801 M | 35.609 M | 46.699 M | -37.188 M | 41.692 M | 27.126 M | |
| Pretax income | 28.245 M | 26.007 M | 33.008 M | 37.313 M | 48.512 M | -38.021 M | 46.707 M | 29.089 M | |
| -7.92% | 26.92% | 13.04% | 30.01% | -178.37% | -222.85% | -37.72% | |||
| Income tax | 6.626 M | 3.259 M | 7.537 M | 7.745 M | 10.750 M | -7.257 M | 11.863 M | 5.814 M | |
| Net income basic | 21.619 M | 22.748 M | 25.471 M | 29.568 M | 37.762 M | -30.764 M | 34.844 M | 23.275 M | |
| 5.22% | 11.97% | 16.08% | 27.71% | -181.47% | 213.26% | -33.20% | |||
| Net income | 21.619 M | 22.748 M | 25.471 M | 29.568 M | 37.762 M | -30.764 M | 34.844 M | 23.275 M | |
| 5.22% | 11.97% | 16.08% | 27.71% | -181.47% | 213.26% | -33.20% |